Skip to content

Anxiety: all studies

Page 268 of 772: studies 2,671 to 2,680 of 7,715, newest first. Back to the anxiety overview

Research

A naturalistic examination of the perceived effects of cannabis on negative affect.

Journal of Affective Disorders August 1, 2018 Carrie Cuttler, Alexander Spradlin, Ryan J Mclaughlin

Cannabis is commonly used to alleviate symptoms of negative affect. However, a paucity of research has examined the acute effects of cannabis on negative affect in everyday life. The current study provides a naturalistic account of perceived changes in symptoms of depression, anxiety, and stress as a function of dose and concentration of Δ9tetrahydrocannabinol (THC) and cannabidiol (CBD). Data...

Psychometric properties of the Child and Adolescent Mindfulness Measure (CAMM) in racial minority adolescents from low-income environments.

Psychological Assessment July 26, 2018 Jason M Prenoveau, Alison A Papadakis, Jacob C S Schmitz et al.

No study has yet assessed the psychometric properties of scores from any mindfulness measure in racial minority adolescents from low-income environments. The present study examined the reliability and validity of Child and Adolescent Mindfulness Measure (CAMM) scores in a nonclinical sample of late adolescents (N = 92) from low-income neighborhoods who predominantly identified as African...

Severe Sleep Deprivation Causes Hallucinations and a Gradual Progression Toward Psychosis With Increasing Time Awake

Frontiers in Psychiatry July 10, 2018 Flavie Waters, Vivian Chiu, Amanda Atkinson et al. 163 citations

Background: Going without sleep for long periods of time can produce a range of experiences, including perceptual distortions and hallucinations. Many questions, however, remain unanswered regarding the types of symptoms which are most reliably elicited, the time of symptom onset, and whether symptoms worsen over time towards psychotic decompensation. Since sleep deprivation exceeding 48 h is...

DOI: 10.3389/fpsyt.2018.00303 (opens in new tab) Anxiety Sleep deprivation Audiology Psychosis +6

2018/7/6/curcumin-breast-cancer-therapeutic-agent-to-replace-allopathic-treatments-with-extensive-side-effects

July 9, 2018 Chu Hsien Lim, Brian D Kangas, Jack Bergman 1 citation

Cancer patients experience a higher rate of depression and anxiety which can result in negative healthcare outcomes. With the limited treatment options available, there has been an interest in using psychedelics such as psilocybin to manage such complications. Recently, two studies demonstrated the

Extremely brief mindfulness interventions for women undergoing breast biopsies: a randomized controlled trial.

Breast cancer research and treatment July 5, 2018 Bertha Andrade Coelho, Sara de Pinho Cunha Paiva, Agnaldo Lopes Da Silva Filho

Purpose: Mindfulness-based programs can reduce stress and help practitioners to have positive attitudes in their daily lives. This randomized controlled trial evaluated the impact of brief Mindfulness interventions on quantitative and qualitative stress parameters in patients undergoing imaging-guided breast biopsies. Methods: Eighty-two women undergoing percutaneous imaging-guided breast...

Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy

International Review of Psychiatry July 4, 2018 Zach Walsh, Michelle S. Thiessen 65 citations

This narrative review examines evidence related to the potential for third wave behaviour therapies to serve as adjuncts to psychedelic-assisted therapy. It identifies shared theoretical foundations for both approaches, and notes enhanced mindfulness, decentering, emotion regulation, and distress tolerance as common mechanisms of action. It also identifies potential targets for which both...

Psychedelics as anti-inflammatory agents

International Review of Psychiatry July 4, 2018 Thomas W. Flanagan, Charles D. Nichols 263 citations

Serotonin (5-hydroxytryptamine, 5-HT)2A receptor agonists have recently emerged as promising new treatment options for a variety of disorders. The recent success of these agonists, also known as psychedelics, like psilocybin for the treatment of anxiety, depression, obsessive-compulsive disorder (OCD), and addiction, has ushered in a renaissance in the way these compounds are perceived in the...

Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress

International Review of Psychiatry July 4, 2018 Stephen Ross 103 citations

Cancer is highly prevalent and one of the leading causes of global morbidity and mortality. Psychological and existential suffering is common in cancer patients, associated with poor psychiatric and medical outcomes. Promising early-phase clinical research (1960s to early 1970s) suggested a therapeutic signal for serotoninergic psychedelics (e.g. psilocybin, LSD) in treating cancer-related...

Ketamine: A Review for Clinicians

FOCUS: The Journal of Lifelong Learning in Psychiatry July 1, 2018 Gerard Sanacora, Rachel B. Katz 16 citations

A growing series of clinical trials and case series now suggest that ketamine-originally used as an anesthetic agent-potentially offers an exciting new treatment option for severe depression. Increasing numbers of studies show that ketamine can provide prompt relief for many depressed patients, including those with severe treatment-refractory depression. Although the effects of a single...

Compassion and Loving-Kindness Meditation: An Overview and Prospects for the Application in Clinical Samples

Harvard Review of Psychiatry July 1, 2018 Johannes Graser, Ulrich Stangier 67 citations

OBJECTIVES: This article presents a brief overview of the empirical evidence of well-established mindfulness interventions and an in-depth review of less-established compassion-based interventions (CBIs) and loving-kindness meditation (LKM). Definitions, cognitive and physiological mechanisms, and methods of assessment are discussed. METHOD: A literature review using the databases Google...